167 related articles for article (PubMed ID: 31350614)
1. Synthesis, in vitro biological activity and docking of new analogs of BIM-23052 containing unnatural amino acids.
Naydenova E; Wesselinova D; Staykova S; Danalev D; Dzimbova T
Amino Acids; 2019 Sep; 51(9):1247-1257. PubMed ID: 31350614
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro antitumor activity of new octapeptide analogs of somatostatin containing unnatural amino acids.
Staykova STs; Wesselinova DW; Vezenkov LT; Naydenova ED
Amino Acids; 2015 May; 47(5):1007-13. PubMed ID: 25655387
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, in vitro biological activity, hydrolytic stability and docking of new analogs of BIM-23052 containing halogenated amino acids.
Danalev D; Borisova D; Yaneva S; Georgieva M; Balacheva A; Dzimbova T; Iliev I; Pajpanova T; Zaharieva Z; Givechev I; Naydenova E
Amino Acids; 2020 Dec; 52(11-12):1581-1592. PubMed ID: 33215308
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, Cytotoxicity and Antioxidant Activity of New Analogs of RC-121 Synthetic Derivatives of Somatostatin.
Naydenova E; Wesselinova D; Staykova S; Goshev I; Vezenkov L
Anticancer Agents Med Chem; 2018; 18(10):1417-1424. PubMed ID: 29667555
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro study of the anticancer activity of new analogs of octreotide.
Staykova S; Naydenova E; Wesselinova D; Kalistratova A; Vezenkov L
Protein Pept Lett; 2012 Dec; 19(12):1257-62. PubMed ID: 22670668
[TBL] [Abstract][Full Text] [Related]
6. Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
Rivier J; Erchegyi J; Hoeger C; Miller C; Low W; Wenger S; Waser B; Schaer JC; Reubi JC
J Med Chem; 2003 Dec; 46(26):5579-86. PubMed ID: 14667212
[TBL] [Abstract][Full Text] [Related]
7. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
[TBL] [Abstract][Full Text] [Related]
8. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J
J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin.
Nagy A; Schally AV; Halmos G; Armatis P; Cai RZ; Csernus V; Kovács M; Koppán M; Szepesházi K; Kahán Z
Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1794-9. PubMed ID: 9465096
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin analogs for diagnosis and treatment of cancer.
Weckbecker G; Raulf F; Stolz B; Bruns C
Pharmacol Ther; 1993 Nov; 60(2):245-64. PubMed ID: 7912834
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship studies optimizing the antiproliferative activity of novel cyclic somatostatin analogues containing a restrained cyclic beta-amino acid.
Sukopp M; Schwab R; Marinelli L; Biron E; Heller M; Várkondi E; Pap A; Novellino E; Kéri G; Kessler H
J Med Chem; 2005 Apr; 48(8):2916-26. PubMed ID: 15828830
[TBL] [Abstract][Full Text] [Related]
12. Differential inhibition of growth hormone secretion by analogs selective for somatostatin receptor subtypes 2 and 5 in human growth-hormone-secreting adenoma cells in vitro.
Tulipano G; Bonfanti C; Milani G; Billeci B; Bollati A; Cozzi R; Maira G; Murphy WA; Poiesi C; Turazzi S; Giustina A
Neuroendocrinology; 2001 May; 73(5):344-51. PubMed ID: 11399907
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, Antiproliferative Effect and In Silico LogP Prediction of BIM-23052 Analogs Containing Tyr Instead of Phe.
Danalev D; Iliev I; Dobrev S; Angelova S; Petrin S; Dzimbova T; Ivanova E; Borisova D; Naydenova E
Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111609
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin receptor-specific analogs: effects on cell proliferation and growth hormone secretion in human somatotroph tumors.
Danila DC; Haidar JN; Zhang X; Katznelson L; Culler MD; Klibanski A
J Clin Endocrinol Metab; 2001 Jul; 86(7):2976-81. PubMed ID: 11443154
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, Anticancer Activity, Docking Calculations and Hydrolytic Stability Studies of Bioconjugates of Monofluorenated Analogue of BIM- 23052.
Danalev D; Iliev I; Borisova D; Dzimbova T; Pajpanova T; Zaharieva Z; Karadjova V; Foteva T; Naydenova E
Protein Pept Lett; 2022; 29(8):721-731. PubMed ID: 35638542
[TBL] [Abstract][Full Text] [Related]
16. Superactive octapeptide somatostatin analogs containing tryptophan at position 1.
Cai RZ; Karashima T; Guoth J; Szoke B; Olsen D; Schally AV
Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2502-6. PubMed ID: 2882520
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for mu opioid receptors.
Pelton JT; Kazmierski W; Gulya K; Yamamura HI; Hruby VJ
J Med Chem; 1986 Nov; 29(11):2370-5. PubMed ID: 2878079
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationship studies of novel somatostatin analogs with antitumor activity.
Kéri G; Mezô I; Vadász Z; Horváth A; Idei M; Vántus T; Balogh A; Bökönyi G; Bajor T; Teplán I
Pept Res; 1993; 6(5):281-8. PubMed ID: 7903057
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]